Counterfeit & unapproved products
Warnings about counterfeit, unapproved or illegally marketed products used in aesthetic and weight-loss practice.
- Editorial attention
- Quiet
- Tracked this week
- 0
- Sources this week
- 0
- Last activity
- Oct 29, 2026
Signal strength reflects editorial attention across tracked sources — not medical certainty or strength of evidence.
- Pending editorial review
A system check is an automated check of the official sources, not a human review. An editorial review is recorded only when one of our editors has reviewed the page.
Counterfeit & unapproved products at a glance
- About this topic
- Warnings about counterfeit, unapproved or illegally marketed products used in aesthetic and weight-loss practice.
- Current status
- No editor-reviewed status summary yet. The official records below update automatically.
- Last updated
- Primary sources
- Latest official record: FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme (opens the source in a new tab) (U.S. Food and Drug Administration, Sep 29, 2026)
What’s the latest on Counterfeit & unapproved products?
0 totalNo briefings on this topic yet. Official records and trials below are updated continuously.
What do the official records show?
Primary sources and peer-reviewed research- FDA Investigation Leads to Charges Against Two Indian Nationals Involved in Transnational Counterfeit Drug Distribution Scheme (opens the source in a new tab)
The U.S. Attorney’s Office for the Middle District of Florida and the Criminal Division of the U.S. Department of Justice today announced federal charges against Swapnadip Roy, 33, and Vicky Ramancha, 37, both Indian nationals.